You are here

24-06-2019 | © picture

Honey bees – what’s in their guts?

Honey bees are an important species for ecology and economy, but their population has shrank worryingly. Prof. Philipp Engel focuses on gut microbiota, a critical factor for bee health, to understand how it evolved and diversified over time. His study addresses timely questions about evolution, ecology, microbiology and could eventually contribute to new strategies for managing bee colonies’ health.

24-06-2019 | © Despoina Mavridou

Bacterial wars

Bacteria fight big. When they meet competitors, they are as aggressive and bloodthirsty as they come. ERC grantee Kevin Foster studies how bacteria wage war against each other. His aim is to understand what led to the evolution of such extreme competitive behaviours, and how to exploit them for our own health.

24-06-2019 | © istockphotos.com

Microbiota: a cure for obesity?

Effective treatment for obesity remains a challenge and the only intervention proven to maintain weight loss is bariatric surgery. Intrigued by the beneficial effect that this procedure has on the composition of gut microbiota, Dr Fredrik Bäckhed explores the possibility of mimicking these changes to develop a treatment for obesity that won’t require going under the knife.

24-06-2019 | © istockphotos.com

Life in the deep – microbes of the abyss

The deep seafloor covers around 70% of our planet’s surface and is home to a diverse community of microorganisms, mostly bacteria. These single-cell life forms inhabit some of the most extreme places in the world, with freezing waters, permanent darkness, high pressure and little food. ERC grantee Antje Boetius studies these microbes in the abyss and their important role for the Earth’s nutrient cycles.

17-06-2019 | Research illustration ©iStockphoto.com/ClubhouseArts | Portrait ©Melanie Verlinden/Reinhart Ceulemans

Biomass crops are energy efficient and climate friendly

EU-funded researchers planted, harvested, processed and analysed the life cycle of woody crops to establish how efficient and environmentally friendly they are as a source of fuel for electricity and heat.

12-06-2019 | © picture

ERC research lends an ear to the voices heard by schizophrenia patients

The ERC-funded ONOFF project is building upon previous efforts to better understand auditory hallucinations (AH) in patients with schizophrenia. Its results could lead to new cognitive and pharmacological treatments.

12-06-2019 | ©istockphoto.com/ThitareeSarmkasat

Wearable devices to help prevent sudden unexpected death through epilepsy

To this day, little is known about sudden unexpected death in epilepsy. Only very few cases have actually been witnessed or monitored. But that might be about to change. Wearable electronics could provide just the solution researchers have been looking for.

29-05-2019 | © picture

Can we grow an artificial retina?

Diseases affecting the retina cause one quarter of worldwide blindness. To date, there are no treatments to restore lost retinal cells and visual function, making it urgent to find new therapeutic approaches. Can stem cells be the solution? Prof. Majlinda Lako aims at growing artificial replicas of the human retina using stem cells.

24-05-2019 | ©iStockphoto CIPhotos

Versatile nanoparticles take aim at complex bone diseases

Multifunctional nanoparticles being developed by EU-funded researchers are set to revolutionise treatments for complex bone diseases, enabling novel therapies for hundreds of millions of people worldwide suffering from bone cancer, bacterial bone infections and osteoporosis.

15-05-2019 | © Hubert Plovier & Patrice Cani, WELBIO

Akkermansia, a friendly bacterium who cares

The abundant presence of a certain bacteria in our intestine, Akkermansia muciniphila, to give it its full name, is an excellent sign according to metabolism and nutrition specialist prof. Patrice Cani. With his team, they discovered the role of these bacteria in reducing cardiometabolic risk factors - like insulin resistance or hypertension – that are leading causes in the development of cardiovascular diseases and type-2 diabetes.